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Buruli ulcer (BU) is a necrotizing skin disease caused by Mycobacterium ulcerans. Previous
studies have shown that wounds of BU patients are colonized with M. ulcerans and several
other microorganisms, including Staphylococcus aureus, which may interfere with wound
healing. The present study was therefore aimed at investigating the diversity and topogra-
phy of S. aureus colonizing BU patients during treatment.
Methodology
We investigated the presence, diversity, and spatio-temporal distribution of S. aureus in 30
confirmed BU patients from Ghana during treatment. S. aureus was isolated from nose and
wound swabs, and by replica plating of wound dressings collected bi-weekly from patients.
S. aureus isolates were characterized by multiple-locus variable number tandem repeat fin-
gerprinting (MLVF) and spa-typing, and antibiotic susceptibility was tested.
Principal Findings
Nineteen (63%) of the 30 BU patients tested positive for S. aureus at least once during the
sampling period, yielding 407 S. aureus isolates. Detailed analysis of 91 isolates grouped
these isolates into 13 MLVF clusters and 13 spa-types. Five (26%) S. aureus-positive BU
patients carried the same S. aureus genotype in their anterior nares and wounds. S. aureus
isolates from the wounds of seven (37%) patients were distributed over two different MLVF
clusters. Wounds of three (16%) patients were colonized with isolates belonging to two dif-
ferent genotypes at the same time, and five (26%) patients were colonized with different
S. aureus types over time. Five (17%) of the 30 included BU patients tested positive for
methicillin-resistant S. aureus (MRSA).
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Conclusion/Significance
The present study showed that the wounds of many BU patients were contaminated with
S. aureus, and that many BU patients from the different communities carried the same
S. aureus genotype during treatment. This calls for improved wound care and hygiene.
Author Summary
Buruli ulcer (BU) is a disease of the skin and soft tissue caused byMycobacterium ulcerans.
The resulting skin lesions provide a niche for survival of other microorganisms such as
Staphylococcus aureus, which may cause delayed wound healing. This study investigated
the presence, diversity, and spatio-temporal distribution of S. aureus in BU patients from
Ghana during treatment by isolating the bacteria from nose and wound swabs or wound
dressings. S. aureus isolates were subsequently characterized by two complementary DNA
typing approaches. This showed that 19 (63%) of the 30 investigated BU patients carried
S. aureus. Five (26%) of these 19 BU patients carried the same S. aureus type in their ante-
rior nares and wounds. Seven (37%) patients carried the same S. aureus type in their
wounds, which is indicative of transmission. Three of them (16%) carried at least two dif-
ferent S. aureus types at the same time in their wounds, while five (26%) carried different
S. aureus types over time. Notably, five (17%) BU patients tested positive for methicillin-
resistant S. aureus (MRSA). These findings imply that the spatio-temporal diversity of
S. aureus in BU is most likely related to factors such as antibiotic pressure, and insufficient
wound care and hygiene.
Introduction
Buruli ulcer (BU) is a neglected necrotizing skin disease caused byMycobacterium ulcerans,
emerging mainly in West Africa with Benin, Côte d’Ivoire and Ghana bearing the highest bur-
den of disease [1]. The disease usually starts as a painless nodule, plaque, oedema or papule
and progresses to form large ulcers when left untreated. The pathology of BU is strongly associ-
ated with the production of mycolactone [2], an immunomodulatory macrolide toxin that
causes tissue necrosis [3]. The regimen for treatment of BU disease is streptomycin and rifam-
picin for 2 months [4–6]. Wound care is an important aspect of treatment but frequently facili-
ties and knowledge on appropriate wound care are missing [7]. BU often results in disfiguring
complications, such as contractures and sometimes amputations. More than half of the patients
have permanent limitations in the performance of daily activities due to seeking treatment at a
later stage [8, 9]. Wounds of most BU patients are colonized with several other microorganisms
in addition toM. ulcerans [10, 11]. Although risk factors for bacterial wound colonization have
not been thoroughly studied to date, delayed treatment and insufficient wound management
might contribute to colonization and prolonged wound healing. Until now there are only two
studies that describe the microorganisms colonizing the wounds of BU patients cultured from
superficial swabs, indicating the presence of Pseudomonas aeruginosa, Proteus mirabilis, Enter-
obacteriaceae, Group A, B and C Streptococcus, and Staphylococcus spp., including Staphylococ-
cus epidermidis and Staphylococcus aureus. Notably, between 33% [11] and 38% [10] of the
detected S. aureus isolates were methicillin-resistant S. aureus (MRSA).
S. aureus is usually a harmless commensal, carried by about 20–30% of the general popula-
tion [12, 13]. However, it can transform into a dangerous pathogen causing a wide range of
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infections in both community and hospital settings. These infectious diseases range from rela-
tively mild skin infections, such as boils and abscesses, to life-threatening conditions such as
pneumonia, bacteremia and endocarditis [14, 15]. Nasal colonization with S. aureus has been
associated with delayed wound healing and prolonged length of stay at burn centres [16] and
previous studies have shown a significant risk for the development of autologous wound infec-
tions by nasal carriers [17, 18]. In BU patients, mycolactone production limits the primary im-
mune responses and recruitment of inflammatory cells to the site of infection. The
mycolactone can thus act as an immunosuppressive agent [19] that predisposes wounds to bac-
terial colonization and infections.
In this study, we aimed at investigating the diversity and topography of S. aureus colonizing
BU patients from Ghana during treatment. S. aureus isolates cultured from nose and wound
swabs, as well as wound dressings were typed by multiple-locus variable number tandem repeat
fingerprinting (MLVF) and spa-typing. Our results show that wounds of three (16%) S. aure-
us-carrying BU patients were colonized with two different genotypes of S. aureus, which were
sometimes found in close proximity to each other. Importantly, 28 (31%) isolates from pa-
tients, who came from different communities but visited the same health centre for treatment,
were grouped into the same MLVF clusters and harboured related spa-types, showing the high
genetic relatedness of S. aureus isolates colonizing BU patients.
Materials and Methods
Ethical approval
The ethical committee of the Noguchi Memorial Institute for Medical Research (NMIMR)
(FEDERALWIDE ASSURANCE FWA 00001824) approved the use of clinical samples for this
investigation. Samples were collected upon written informed consent from all patients.
Confirmation of BU cases
Sampling was done at the Pakro Health Centre, in the Eastern region of Ghana. Patients with
suspected BU from different communities reported to the health centre for diagnosis. Using
the BU 01.N form (www.who.int/buruli/control/ENG_BU_01_N), information such as the
age, place of residence, size of lesion (categories: I 5 cm, II 5–15 cm and III 15 cm or at
critical sites such as the eye and genitals) was obtained before sampling for diagnosis. For the
diagnosis of BU, wound swabs from ulcers were collected from patients and kept in 15 ml Fal-
con tubes containing 2 ml transport medium (Middlebrook 7H9 supplemented with polymyx-
in, amphotericin B, nalidixic acid, trimethoprim and azlocillin [PANTA]). DNA was extracted
from the samples using the modified Boom method [20]. IS2404 nested PCR was performed as
described previously [21]. Patients whose samples tested positive for the presence of the IS2404
target were confirmed to have BU. Patients visited the health centre daily for antibiotic therapy
with rifampicin and streptomycin for two months, and wound management twice a week until
their wounds healed.
Cultivation of S. aureus
Nose and wound swabs of 30 PCR-confirmed BU patients were collected bi-weekly from De-
cember 2012 until July 2013 (sampling time points designated as: t1 to t13) or until their
wounds healed. The patient material was transported to the NMIMR the same day for culture.
Swabs were streaked on cysteine lactose electrolyte-deficient (CLED) agar and incubated at
37°C for ~24 h. S. aureus was subcultured on blood agar (BA) plates containing 5% sheep
blood and incubated overnight at 37°C. In addition, wound dressings that had covered the
Spatio-Temporal Distribution of S. aureus in BU
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wounds of patients for a maximum of three days were collected. The topography of S. aureus
in the wounds was determined by replica plating the wound dressing on CLED agar and incu-
bation of the plates at 37°C for ~24 h. Initially, between 50 and 82 potential S. aureus colonies
per patient were selected from the wound replica plates and subcultured on CLED agar until
colonies were pure. This number was later reduced to 2 to 10 colonies per patient; the respec-
tive colonies were selected based on morphology, size and color/pigmentation. In comparison
with our initial sample size, this convenience sample was sufficient to pick up>95% of the
S. aureus types present in each lesion. Identification of S. aureus was confirmed using the Pas-
torex Staph Plus test (Bio-Rad, Marnes-la-Coquette, France). S. aureus isolates were subse-
quently transported to the University Medical Center Groningen (UMCG) on tryptic soy agar
containing 5% sheep blood, subcultured on BA, and stored in 17% glycerol at -80°C for
further analyses.
Identification of other microorganisms in the wounds of BU patients
Colonies from the replica plates that did not phenotypically resemble S. aureus were identified
using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-
TOF MS) with a microflex LT Biotyper (Bruker Daltonics, Bremen, Germany) according to
manufacturer’s instructions. Briefly, different colonies were applied onto the MALDI-TOFMS
target and overlaid with 1 µl matrix solution, which is a saturated solution of α-cyano-4-
hydroxycinnamic acid in 50% acetonitrile and 2.5% trifluoroacetic acid. The target was then
air-dried at room temperature and analyzed in the Biotyper. A log score is calculated by the
Biotyper software by comparing data of the unknown organism with data of reference organ-
isms for identification of the unknown organism (log score 2—reliable species identification
(ID); log score> 1.7< 2 reliable genus ID; log score< 1.7 no reliable ID).
DNA extraction
Total DNA was prepared from S. aureus colonies taken from BA plates as described by
Glasner et al. [22]. Briefly, 2 to 3 colonies were resuspended in 500 μl of Tris-EDTA (TE) buffer
(pH 8.0) containing zirconia/silica beads with a diameter of 100 µm in 1.5 ml bead-beating
tubes with screw caps. The cells were disrupted using a Precellys bead beater (Bertin Technolo-
gies, Saint Quentin en Yvelines, France) in 3 pulses of 30 s at a speed of 5,000 rpm with 30 s in-
tervals between the pulses. Samples were subsequently heated to 95°C for 10 min and
centrifuged (14,000 rpm) at 4°C for 10 min. A volume of 200 µl of the resulting supernatant
fraction was transferred into a fresh tube and stored at -20°C until further use.
Detection of the accessory gene regulator,mecA and Panton-Valentine
leukocidin genes
All S. aureus isolates were screened for the presence of themecA, accessory gene regulator (agr)
(types I, II, III and IV) and Panton-Valentine leukocidin (PVL) (lukS-PV/lukF-PV) genes by
PCR as described previously [23–26].
MLVF
MLVF was performed using a modified protocol as described by Glasner et al. [22] and Sabat
et al. [27]. Briefly, 1 µl of genomic DNA was subjected to a multiplex PCR targeting seven
staphylococcal genes (sdrC, sdrD, sdrE, clfA, clfB, sspA and spa). The resulting PCR products
were first separated on 2% agarose gels, because this is most economic. Subsequently, MLVF
samples from S. aureus isolates with clearly different MLVF banding patterns, or the same
Spatio-Temporal Distribution of S. aureus in BU
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MLVF banding patterns but different agr,mecA and PVL profiles were further analyzed with
microfluidic DNA 7500 chips using the Bioanalyzer 2100 (Agilent Technologies, Palo Alto,
USA). Notably, these chips have a higher resolution than agarose gels, and the recorded elec-
tropherograms can be used for automated data processing. To this end, 1 µl of each PCR reac-
tion was loaded onto a DNA 7500 chip. Next, the PCR-amplified DNA fragments were
separated by electrophoresis and electropherograms were automatically recorded according to
the manufacturer’s instructions. In each Bioanalyzer run, the clinical S. aureus isolate M2, iso-
lated at the UMCG [27] was added as a technical control to ensure the reproducibility of the
generated data. The data generated with the Bioanalyzer were imported as CSV files into the
GelCompar II software (Applied Maths, Kortrijk, Belgium) for analysis. The position tolerance
and optimization were set at 0.9% and 0.5% respectively. Using the selected position tolerance,
the M2 control isolate for all Bioanalyzer runs showed identical MLVF banding patterns. Pair-
wise similarity coefficients were calculated using the dice formula and the dendrogram was
generated using the unweighted pair group method using average linkages (UPGMA). Identi-
cal patterns were designated as the same MLVF subtype. After visual inspection of the MLVF
dendrogram, six different cut-off values (66%, 77%, 79%, 81%, 82% and 84%) were chosen for
testing the concordance between MLVF and spa-typing. The concordance between the two
DNA typing methods was calculated with the Ridom EpiCompare software version 1.0 as de-
scribed previously [27]. The cut-off value with the highest concordance between the two typing
methods was used for clustering of the MLVF patterns.
spa-typing
spa-typing of the 91 S. aureus isolates was performed as previously described by Harmsen et al.
[28]. DNA sequences were obtained using an ABI Prism 3130 genetic analyser (Applied Bio-
systems, Foster City, USA). spa-types were determined using the Ridom Staph Type software
version 2.2.1 (Ridom GmbH, Würzburg, Germany) [28]. The spa-types were grouped into spa-
clonal complexes (spa-CCs) with the based upon the repeat pattern (BURP) algorithm utilizing
the Ridom Staph Type software. spa-types shorter than 4 repeats were excluded from the analy-
sis, and spa-types were clustered if the costs were 4.
Antibiotic susceptibility testing
Antibiotic susceptibility was determined with the VITEK 2 system (AST-P633, bioMerieux
Corporate, Marcy l’Etoile, France) according to the manufacturer’s instructions. The used card
contained the following antibiotics: benzylpenicillin, cefoxitin, chloramphenicol, ciprofloxacin,
clindamycin, erythromycin, fosfomycin, fusidic acid, gentamicin, kanamycin, linezolid, mupir-
ocin, oxacillin, rifampicin, teicoplanin, tetracycline, tobramycin, trimethoprim/sulfamethoxa-
zole and vancomycin. The VITEK 2 minimum inhibitory concentration (MIC) results were
interpreted using the Advanced Expert System following EUCAST guidelines (www.eucast.
org).
Results
Thirty of 60 patients receiving treatment at the Pakro Health Centre were confirmed with BU
during the time of investigation. These patients had a median age of 44 years, and presented
the three disease categories as follows: 30% presented category I lesions, 46.7% category II le-
sions and 23.3% category III lesions. Clinical signs such as excessive inflammation, exudates
and severe pain in the first month of the antimicrobial therapy were observed for the wounds
of, respectively, one (3%), two (7%), and 15 (50%) of the 30 BU patients. Samples from 19
(63.3%) of these patients tested positive for S. aureus at least once. These 19 patients came
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from 14 different communities in Ghana (Fig. 1). S1 Fig. displays the frequency of S. aureus
isolation from the 19 BU patients at different time points (marked t1 to t13). Specifically,
S. aureus was cultured at least once from the nasal swabs from seven (37%) of these 19 patients,
wound swabs from ten (53%) patients and wound dressings from 15 (79%) patients.
MLVF
The S. aureus isolates from the different patient samples were typed by MLVF. Altogether, this
involved 407 S. aureus isolates from 19 patients. The respective MLVF banding patterns were
initially analyzed on agarose gels. Subsequently, 91 S. aureus isolates with clearly different
MLVF banding patterns, or the same MLVF banding patterns but different agr,mecA and PVL
profiles were selected for a further characterization with microfluidic DNA 7500 chips using
the Bioanalyzer 2100. The Bioanalyzer data were then used to generate the dendrogram shown
in Fig. 2. Altogether, the MLVF analysis resulted in 24 different banding patterns, of which ten
patterns were represented by two or more isolates and 14 patterns by a single isolate. The appli-
cation of the different cut-off values (66%, 77%, 79%, 81%, 82% and 84%) with the subsequent
analyses of the concordance with the identified spa-types resulted in Adjusted Rand’s coeffi-
cients of 0.952, 0.973, 0.979, 0.980, 0.938 and 0.907, respectively. The cut-off value of 81%
yielded the highest concordance (0.980) resulting in 13 clusters of which eight comprised two
or more isolates. These 13 clusters were denoted as A (n = 28), B (n = 1), C (n = 1), D (n = 2),
E (n = 4), F (n = 25), G (n = 2), H (n = 10), I (n = 1), J (n = 1), K (n = 1), L (n = 9) and
M (n = 6). The two major clusters A and F were composed of 28 and 25 isolates respectively,
and they were derived from eight patients each (Fig. 2, S1 Table). The clusters A, D, F and G in-
cluded two or more isolates from the anterior nares and the wounds of individuals patients
(five [26%] of 19 BU patients), suggesting autoinoculation from the nose to the wound, or
vice versa. Furthermore, both clusters H and L include isolates from the wounds of different pa-
tients, which is indicative for transmission events between patients. This may also be the case
Figure 1. Map of Ghana indicating the region and communities fromwhich the 19 BU patients colonized with S. aureus originated.
doi:10.1371/journal.pntd.0003421.g001
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Figure 2. MLVF dendrogram of 91 S. aureus isolates from BU patients. The dendrogram was generated using the UPGMA algorithm. Additionally, seven
technical controls designated M2 were included in the dendrogram. The respective MLVF clusters and spa-types are indicated on the right side of
the dendrogram.
doi:10.1371/journal.pntd.0003421.g002
Spatio-Temporal Distribution of S. aureus in BU
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for the MLVF cluster M, which comprised six isolates from the anterior nares of two patients
that were not detected in their wounds or wound dressings (Fig. 2, S1 Table).
Spa-typing
The 91 isolates examined by MLVF on the Bioanalyzer were also characterized by spa-typing.
This yielded 13 spa-types including one new spa-type (t12836). Specifically, the numbers of
identified repeats ranged between 3 (t11375) and 11 (t084) (Table 1). Seven spa-types were rep-
resented by two or more isolates and six were represented by single isolates. BURP analysis re-
sulted in no spa-CCs in the present collection, but grouped 67 isolates (74% of all investigated
isolates) in three groups with no founder (Fig. 3). Twenty isolates (22% of all investigated iso-
lates) comprising six spa-types (46% of all spa-types) were identified as singletons (Fig. 3), and
Table 1. spa-types of 91 S. aureus isolates from the anterior nares and wounds of 19 BU patients.
Patient No. Time point of sampling Spa-type spa repeats No. of isolates
2 t2, t3, t8, t9 t786 07–12–21–17–13–34–34–33–34 8
3 t2, t7, t8, t9, t10, t11 t084 07–23–12–34–34–12–12–23–02–12–23 8
t8 t355 07–56–12–17–16–16–33–31–57–12 2
t9 t314 08–17–23–18–17 2
4 t7 t084 07–23–12–34–34–12–12–23–02–12–23 1
5 t11 t355 07–56–12–17–16–16–33–31–57–12 2
6 t1 t7835 07–82–21–17–34–34–16–34–33–13 2
t11 t355 07–56–12–17–16–16–33–31–57–12 1
7 t4 t355 07–56–12–17–16–16–33–31–57–12 5
t5 t786 07–12–21–17–13–34–34–33–34 1
t8 t1096 07–56–17–16–16–33–31–57–12 1
t6, t8 t939 04–16–34–12–34–12 2
t6, t8, t11 t084 07–23–12–34–34–12–12–23–02–12–23 10
t11 t002 26–23–17–34–17–20–17–12–17–16 1
10 t2, t3, t4, t5, t8 t355 07–56–12–17–16–16–33–31–57–12 12
11 t2, t5 t355 07–56–12–17–16–16–33–31–57–12 2
12 t8, t13 t314 08–17–23–18–17 2
t13 t12836 08–13–13–17–34–16–34 1
13 t1 t186 07–12–21–17–13–13–34–34–33–34 1
17 t2 t346 07–23–12–34–12–12–23–02–12–23 1
t2, t4 t11375 07–56–12 4
18 t5 t355 07–56–12–17–16–16–33–31–57–12 1
19 t3 t786 07–12–21–17–13–34–34–33–34 1
21 t7 t084 07–23–12–34–34–12–12–23–02–12–23 1
22 t4 t2724 26–17–34–20–17–12–17–16 1
t6, t8, t9, t12 t084 07–23–12–34–34–12–12–23–02–12–23 5
t6, t9 t314 08–17–23–18–17 4
t6, t8, t9, t12 t939 04–16–34–12–34–12 4
24 t5 t355 07–56–12–17–16–16–33–31–57–12 1
26 t9 t084 07–23–12–34–34–12–12–23–02–12–23 1
t9 t314 08–17–23–18–17 1
27 t11 t084 07–23–12–34–34–12–12–23–02–12–23 1
30 t12 t084 07–23–12–34–34–12–12–23–02–12–23 1
doi:10.1371/journal.pntd.0003421.t001
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four isolates (4% of all investigated isolates) comprising one spa-type (t11375, 8% of all spa-
types) were excluded.
Bacterial topography in wounds of BU patients
To determine the bacterial topography in the wounds of BU patients, used wound dressings
were replica plated onto CLED agar plates. This led to the observation of either distinct colo-
nies or confluent growth of S. aureus in combination with other microorganisms. Species iden-
tification with the microflex LT Biotyper revealed the presence of Acinetobacter baumannii,
Corynebacterium striatum, Enterococcus casseliflavus, Enterococcus faecalis, Escherichia coli,
Klebsiella pneumoniae, Pseudomonas aeruginosa, S. epidermidis, S. haemolyticus, and/or
S. hominis in wound dressings from 15 (79%) of the 19 included patients. In fact, highly hetero-
geneous bacterial wound populations made it impossible to detect S. aureus in the case of three
BU patients. In the case of one patient (no. 30) no S. aureus was identified upon replica plating
of the wound dressings, and the only S. aureus isolate of this patient was obtained at one time
point from the anterior nares (Fig. 2).
The MLVF typing results of the 49 S. aureus isolates obtained from 15 (79%) of the 19 in-
cluded patients through replica plating of wound dressings were distributed among five differ-
ent clusters (A, D, F, H and L) (Fig. 2, S1 Table). In this case, the number of isolates selected
from a single patient varied from one to six. Interestingly, four of the five clusters, namely A
(n = 7), F (n = 7), H (n = 3) and L (n = 4), harboured isolates from patients who reside in differ-
ent communities (Fig. 2, S1 Table). With regard to the identified S. aureus diversity over time
in the wounds of the 15 BU patients, different observations were made. In the case of 11 (73%)
patients the same S. aureus isolates remained detectable over time. For example, patient 2 was
colonized at four sampling time points with S. aureus isolates that belonged to cluster H, while
patients 10 and 11 carried isolates of cluster F for the entire duration of the study (Fig. 2, S1
Table). Three other patients carried S. aureus belonging to two MLVF clusters in one wound at
one time point. For example, this was the case for patient 22 who was colonized with isolates
that grouped in clusters A and L at time point t6 (Fig. 4, S1 Table). For five (33%) patients a
temporal change of S. aureus genotypes in their wounds was detected as judged by MLVF and
Figure 3. Population structure of the 91 S. aureus isolates from BU patients. The population structure
was obtained by BURP analysis. In the present S. aureus collection, comprising 13 different spa-types no
spa-CCs could be generated. The BURP analysis grouped isolates together into three groups with no
founder, comprising 27 (30% of all isolate), 29 (32% of all isolate) and 11 (12% of all isolate) S. aureus
isolates, respectively. Twenty isolates (22% of all isolates) comprising six spa-types (46% of all spa-types)
were identified as singletons, and four isolates (4% of all isolates) comprising one spa-type (t11375, 8% of all
spa-types) were excluded. The circle size is proportional to the number of isolates in each cluster.
doi:10.1371/journal.pntd.0003421.g003
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spa-typing. For example, patient 3 was colonized with S. aureus isolates that belonged to cluster
A at time t2, cluster F at t8, and cluster L at t9 (S1 Table). Furthermore, patient 12 was colo-
nized with S. aureus of cluster L at t8, and at t13 with clusters C and L (S1 Table). Moreover,
patient 7 was found to be colonized by S. aureus belonging to four MLVF clusters over time.
This patient carried S. aureus of cluster F at t4, clusters F and H at t5, cluster A at t6, clusters A
and D at t8, and cluster A at t11 (Fig. 4, S1 Table).
Antibiotic resistance pattern and detection ofmecA, agr and PVL genes
All 91 S. aureus isolates were tested for their antibiotic susceptibility and the results are pre-
sented in Table 2. All 91 isolates were found to be susceptible to clindamycin, fusidic acid, gen-
tamicin, linezolid, mupirocin, tobramycin and vancomycin, while resistance to penicillin was
observed in 90 isolates (99%) (S1 Table). Chloramphenicol resistance was observed for 59
(65%) isolates that belonged to the MLVF clusters A, F, G, H, J, L and M. Two isolates (2%) of
clusters F and K were resistant to ciprofloxacin. Only one isolate that was grouped in cluster F
was resistant to fosfomycin and teicoplanin and displayed an intermediate resistance pheno-
type to kanamycin. Seven (8%) isolates from the clusters A, F and L were resistant to rifampi-
cin. The latter isolates were obtained from 4 (21%) of the 19 S. aureus-positive patients; from
three of these patients, rifampicin resistant isolates were obtained 1–5 months after therapy
with rifampicin and streptomycin, while rifampicin resistant isolates from one patient were ob-
tained two weeks before the end of the antibiotic therapy. Seventy (77%) isolates belonging to
Figure 4. S. aureuswound topography in BU patients.Used dressings from wounds of BU patients were
replica-plated onto CLED agar plates, and S. aureus colonies thus obtained were typed by MLVF. S. aureus
colonies belonging to different MLVF clusters are shown in different colors: cluster A, red circles; cluster D,
blue circles; cluster F, yellow circles; cluster H, green circle and cluster L, purple circles. (A) Replica plate of a
wound dressing collected from patient 7 at time point t8 with S. aureus colonies belonging to clusters A and D,
(B) Replica plate of a wound dressing collected from patient 7 at time t5 with S. aureus colonies belonging to
clusters F and H. (C) Replica plate of a wound dressing collected from patient 22 at time t6 with S. aureus
colonies belonging to clusters A and L.
doi:10.1371/journal.pntd.0003421.g004
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eight clusters (A, D, F, G, H, I, J and L) were resistant to tetracycline. Twenty-seven (30%) iso-
lates belonging to clusters A, B, F, I and L were resistant to trimethoprim/sulfamethoxazole (S1
Table). Twelve (13%) isolates belonging to MLVF clusters F, H, J and K were resistant to cefox-
itin and oxacillin, which implies that they are MRSA. Nonetheless, one of these tested negative
for themecA andmecC genes, suggesting that an as yet unidentified determinant causes the
cefoxitin and oxacillin resistance. Interestingly, in wounds of three of the five patients from
which oxacillin resistant isolates belonging to MLVF clusters F and H were collected, we also
identified methicillin-sensitive S. aureus (MSSA) of the same genotype (S1 Table).
Lastly, agr typing revealed the presence of all four agr types among this collection (type I: 28
(31%) isolates, type II: 26 (29%) isolates, type III: 13 (14%) isolates, and type IV: 17 (19%) iso-
lates). The six (7%) isolates that were grouped in cluster M tested negative for the agr gene, and
for one isolate (1%) originating from cluster F no agr type could be determined as the obtained
PCR product did not match with any of the known type-specific PCR products. Six patients
were colonized with S. aureus isolates grouping into the same MLVF clusters, but belonging to
different agr groups (S1 Table). Fifty-five (60%) of the 91 isolates obtained from 15 (79%) of
the 19 patients over time tested positive for the PVL-encoding genes (S1 Table).
Discussion
In the present study, we have explored the diversity and topography of S. aureus in BU patients
as well as the temporal changes in the population of this opportunistic pathogen during patient
treatment. To investigate the spatio-temporal distribution of S. aureus, MLVF and spa-typing
were used for the determination of their genotypes.
It has been reported previously that over 80% of the people with skin lesions are nasal S. au-
reus carriers [29, 30]. Furthermore, van der Kooi-Pol et al. [31, 32] reported that about 62–75%
Table 2. Antibiotic resistances of the 91 S. aureus study isolates.
Antibiotic No. (resistance rate %)
Ciproﬂoxacin 2 (2.2)
Chloramphenicol 59 (64.8)
Clindamycin (constitutive) 0 (0)
Erythromycin 2 (2.2)
Fosfomycin 1 (1.1)













For details on the antibiotic resistances of the respective study isolates, please see S1 Table in the
Supporting Information.
doi:10.1371/journal.pntd.0003421.t002
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of the patients with the genetic blistering disease epidermolysis bullosa (EB) were colonized
with S. aureus in the anterior nares, depending on the absence or presence of chronic wounds,
and that 69–92% of these patients carried S. aureus in their wounds [32]. In ~60% of the inves-
tigated cases, EB patients carried the same type of S. aureus in their upper respiratory tract and
wounds suggesting a high frequency of auto-inoculation [31]. In the present study, 19 BU pa-
tients tested positive for S. aureus at least once; 37% of these BU patients were found to contain
S. aureus at least once in the anterior nares, 79% contained S. aureus in their wounds at any
one point in time, and 26% contained S. aureus with the same genotype in their wounds and
nose. Nasal carriage of S. aureus in the healthy human population varies between 12–30%
[13, 17]. It thus seems that the nasal S. aureus carriage rate in BU patients (23% of all 30 includ-
ed patients) resembles that of the healthy population, and is much lower than in EB patients.
On the other hand, the frequency of S. aureus wound colonization in all 30 included BU pa-
tients (50%) is slightly lower than that of EB patients, while the potential auto-inoculation be-
tween the nose and wounds of BU patients (26%) as evidenced by the detection of S. aureus
isolates with the same MLVF and spa-types at both body sites appears substantially lower than
observed for EB patients. These differences may relate to the fact that EB patients suffer from
recurring wounds right from the moment of birth, while BU patients develop wounds only
upon infection withM. ulcerans. Accordingly, EB patients are likely to be exposed to S. aureus
for much longer periods of time than BU patients.
Our present typing analyses show that 98% of the isolates from BU patients that group in
the same MLVF cluster have the same spa-type (Fig. 2). Only cluster D contained two isolates
with different and unrelated spa-types, namely t355 and t1096. Within the collection of the 91
investigated isolates, most isolates (58%) were grouped in the MLVF clusters A and F with the
respective spa-types t084 and t355. In a recent study, these spa-types have been reported as the
most prevalent types in healthcare institutions in Ghana [33]. Notably, the wounds of the ma-
jority of patients followed over time were continuously colonized with the same S. aureus
MLVF type, and only seven BU patients carried S. aureus isolates belonging to different unre-
lated types. Contrary to these findings, highly variable S. aureus types have been isolated from
EB and cystic fibrosis patients [34, 35]. Moreover, the genotypes of patient isolates identified in
the present study were not specific for particular patients. Instead, we frequently found that dif-
ferent BU patients carried S. aureus with the same MLVF and spa-types at the same or succes-
sive time points (S1 Table). This suggests possible patient transmission events. Since the
studied BU patient cohort is composed of patients who all visited the Pakro Health Centre at
the same time for antibiotic therapy and wound care treatment, it is conceivable that (indirect)
patient-to-patient transmission of S. aureus has occurred during this event. This view would be
consistent with the finding that spa-types t084 and t355 are dominant in healthcare settings in
Ghana [33]. On the other hand, we cannot rule out the possibility that transmission events
may have occurred in the communities. For the present study we were, unfortunately, unable
to obtain samples from the cleansing solutions, surfaces of dressing equipment and the health-
care workers who dressed the wounds of the patients. Samples from the household members of
the investigated BU patients could have further informed us on how S. aureus and other de-
tected wound-colonizing bacteria are potentially transmitted from family members to patients
(i.e. during wound dressing) and subsequently via the healthcare setting to other patients. Lack
of information on these potential sources makes it difficult to infer the exact source from
which these patients were colonized with any certainty. Although the evidence for inter-patient
S. aureus transmission events that we present here is strong, to obtain final proof for the idea
that the S. aureus isolates with identical MLVF and spa-types from different patients reflect
transmission events, it will be necessary to analyze these isolates by a more discriminatory typ-
ing method such as whole-genome sequencing (WGS). Data generated by WGS provide a
Spatio-Temporal Distribution of S. aureus in BU
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003421 February 6, 2015 12 / 17
much higher resolution in the investigation of transmission events than any of the more con-
ventional typing methods [36–38].
The analysis of the bacterial topography of the wounds of BU patients showed that wound-
colonizing S. aureus isolates belonged to the same or two different MLVF clusters at particular
time points. A similar investigation on chronic wounds of EB patients also showed the co-
existence of distinct S. aureus types in close proximity, although in this case the co-existence of
up to six distinct S. aureus types was observed [35]. Furthermore, our present analysis of the
bacterial wound topography of BU patients over time showed that the population of S. aureus
may shift (Fig. 2, Table 1). This shift may relate to the use of rifampicin and streptomycin for
treatment of theM. ulcerans infection, but this needs to be further investigated. In any case,
only 13% of all the 30 included patients carried rifampicin resistant S. aureus isolates in the
present study, indicating that the BU treatment might not have a strong effect on the genetic
population structure of S. aureus in the wounds.
A total of 99%, 77% and 65% of the collected S. aureus isolates were resistant to penicillin,
tetracycline and chloramphenicol, respectively. This is not surprising as these antibiotics are
frequently prescribed in healthcare institutions or readily accessible in pharmacies in Ghana.
Similarly, a high resistance to penicillin (73.7–100%) [39, 40] and tetracycline (21.8–92%)
[41, 42] has been reported for MSSA isolates in other African countries, including Algeria, Ni-
geria, and Sao Tome and Principe. Notably, S. aureus isolates that belonged to the same MLVF
cluster from individual BU patients included in our present study often presented the same an-
tibiotic resistance pattern. Furthermore, 13% of the 91 selected S. aureus isolates were MRSA,
one of which was a borderline oxacillin resistant S. aureus. These MRSA isolates were obtained
from 5 of the 30 included BU patients (17%). This implies that the MRSA carriage rate in the
sampled BU patient cohort was lower than the 33% [11] and 38% [10] observed in other co-
horts of BU patients. From a clinical point of view, it is relevant to mention that three patients
carried MRSA and MSSA at the same time, indicating that MRSA can be missed if only single
isolates are tested for resistance. This could then result in an inappropriate antibiotic therapy.
Some BU patients were colonized with S. aureus that belonged to the same MLVF cluster
but had different agr types. The presence of different agr types of the same S. aureus genotype
may play different roles by cross-group interference, which may confer a selective survival ad-
vantage for these genotypes over time [43]. agr-negative S. aureus have been shown to have
high colonization potential through the formation of biofilms thereby contributing to persis-
tent infection [44, 45]. MLVF cluster M, comprised isolates that are all agr-negative. These iso-
lates were obtained from the anterior nares of two patients suggesting that these individuals
may be persistent nasal S. aureus carriers. Wound colonization of BU patients with PVL-
positive S. aureus was observed for 79% patients, which appears in line with previous studies
that have associated PVL with skin and soft tissue infections [46, 47]. It is tempting to
speculate that this could easily be confused with the commonly observed paradoxical response
in BU patients [6], where the size of lesions increases upon effective antibiotic therapy against
M. ulcerans.
In summary, the present study showed that 26% of the investigated BU patients were colo-
nized with the same S. aureus types in the anterior nares and wounds during the time period of
investigations. Furthermore, patients were colonized with S. aureus types that grouped up to
two MLVF clusters at the same time point. Over time, changes in the S. aureus wound popula-
tion were observed. Notably, our data suggest that patient transmission events have occurred
since some S. aureusMLVF clusters were shared by different patients at overlapping time
points. This emphasizes the need for appropriate wound care and hospital hygiene. Since S. au-
reus is in general capable of interfering with wound healing and since several of the identified
isolates are resistant to clinically relevant antibiotics, it will be important to further investigate
Spatio-Temporal Distribution of S. aureus in BU
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the role of S. aureus in wound healing in BU patients and to uncover the reservoirs from which
this pathogen is transmitted to this patient group.
Supporting Information
S1 Table. S. aureus isolates from BU patients listed in the order of the MLVF dendrogram.
(XLSX)
S1 Fig. Frequency of S. aureus isolation from different BU patients. The different colors rep-
resent the types of samples from which S. aureus isolates were obtained: yellow—nasal swab,
orange—wound swab, red—wound dressing. A white field indicates that the patient did not re-
port to the healthcare centre, and a grey field that S. aureus was not detected. The successive
time points at which samples were collected at the health centre are marked t1 to t13.
(TIF)




The authors express their gratitude to the Buruli ulcer health team from the Pakro Health Cen-
tre (Ghana) for their help in sample collection and treatment of the patients, Willy Baas, Bri-
gitte Dijkhuizen and Erwin Raangs for technical support in spa-typing, and Tjibbe Donker for
refining the map in Fig. 1.
Author Contributions
Conceived and designed the experiments: NAA CG AA JMvD TSvdW YS. Performed the ex-
periments: NAA CST IP. Analyzed the data: NAA, CG. Contributed reagents/materials/analy-
sis tools: JMvD NKK AA TSvdW YS. Wrote the paper: NAA CG AA TSvdW JWR JMvD YS.
References
1. Jassens PG; Pattyn SR; Meyers WM; Portaels F (2005) Buruli ulcer: An historical overview with updat-
ing to 2005. Bull Séanc Acad R Sci O-m 51: 165–199.
2. Coutanceau E, Marsollier L, Brosch R, Perret E, Goossens P, et al. (2005) Modulation of the host im-
mune response by a transient intracellular stage of Mycobacterium ulcerans: The contribution of endog-
enous mycolactone toxin. Cell Microbiol 7: 1187–1196. doi: 10.1111/j.1462-5822.2005.00546.x PMID:
16008585
3. Van Der Werf TS, Stinear T, Stienstra Y, Van Der Graaf WTA, Small PL (2003) Mycolactones and My-
cobacterium ulcerans disease. Lancet 362: 1062–1064. doi: 10.1016/S0140-6736(03)14417-0 PMID:
14522538
4. Chauty A, Ardant M-F, Adeye A, Euverte H, Guédénon A, et al. (2007) Promising clinical efficacy of
streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
5. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, et al. (2005) Efficacy of the combination
rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in
humans. Antimicrob Agents Chemother 49: 3182–3186. doi: 10.1128/AAC.49.8.3182-3186.2005
PMID: 16048922
6. Nienhuis WA, Stienstra Y, ThompsonWA, Awuah PC, Abass KM, et al. (2010) Antimicrobial treatment
for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet 375: 664–672.
Available: http://www.ncbi.nlm.nih.gov/pubmed/20137805. Accessed 4 May 2014. doi: 10.1016/
S0140-6736(09)61962-0 PMID: 20137805
7. Velding K, Klis S-A, Abass KM, TuahW, Stienstra Y, et al. (2014) Wound Care in Buruli Ulcer Disease
in Ghana and Benin. Am J Trop Med Hyg. Available: http://www.ncbi.nlm.nih.gov/pubmed/24914002.
doi: 10.4269/ajtmh.13-0255 PMID: 24914002
Spatio-Temporal Distribution of S. aureus in BU
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003421 February 6, 2015 14 / 17
8. Barogui Y, Johnson RC, van der Werf TS, Sopoh G, Dossou A, et al. (2009) Functional limitations after
surgical or antibiotic treatment for Buruli ulcer in Benin. Am J Trop Med Hyg 81: 82–87. PMID:
19556571
9. Stienstra Y, van Roest MHG, vanWezel MJ, Wiersma IC, Hospers IC, et al. (2005) Factors associated
with functional limitations and subsequent employment or schooling in Buruli ulcer patients. Trop Med
Int Health 10: 1251–1257. doi: 10.1111/j.1365-3156.2005.01519.x PMID: 16359405
10. Barogui YT, Klis S, Bankole H, Sopoh GE, Mamo S, et al. (2013) Towards Rational Use of Antibiotics
for Suspected Secondary Infections in Buruli Ulcer Patients. PLoS Negl Trop Dis 7. doi: 10.1371/
journal.pntd.0002010 PMID: 23359827
11. Yeboah-Manu D, Kpeli GS, Ruf MT, Asan-Ampah K, Quenin-Fosu K, et al. (2013) Secondary Bacterial
Infections of Buruli Ulcer Lesions Before and After Chemotherapy with Streptomycin and Rifampicin.
PLoS Negl Trop Dis 7. doi: 10.1371/journal.pntd.0002191 PMID: 23658847
12. Nouwen JL, Ott A, Kluytmans-Vandenbergh MFQ, Boelens HAM, Hofman A, et al. (2004) Predicting
the Staphylococcus aureus nasal carrier state: derivation and validation of a “culture rule”. Clin Infect
Dis 39: 806–811. doi: 10.1086/423376 PMID: 15472812
13. Wertheim HFL, Melles DC, Vos MC, van LeeuwenW, van Belkum A, et al. (2005) The role of nasal car-
riage in Staphylococcus aureus infections. Lancet Infect Dis 5: 751–762. doi: 10.1016/S1473-3099(05)
70295-4 PMID: 16310147
14. Van Belkum A, Melles D, Nouwen J, van LeewenW, vanWamel W, et al. (2009) Co-evolutionary as-
pects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9: 32–47. Avail-
able: http://www.sciencedirect.com/science/article/pii/S1567134808001779. Accessed 30 April 2014.
doi: 10.1016/j.meegid.2008.09.012 PMID: 19000784
15. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520–532. doi: 10.1056/
NEJM199808203390806 PMID: 9709046
16. Kooistra-Smid M, Nieuwenhuis M, van Belkum A, Verbrugh H (2009) The role of nasal carriage in
Staphylococcus aureus burn wound colonization. FEMS Immunol Med Microbiol 57: 1–13. doi: 10.
1111/j.1574-695X.2009.00565.x PMID: 19486150
17. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiolo-
gy, underlying mechanisms, and associated risks. Clin Microbiol Rev 10: 505–520. PMID: 9227864
18. Bode LGM, Kluytmans JAJW, Wertheim HFL, Bogaers D, Vandenbroucke-Grauls CMJE, et al. (2010)
Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362: 9–17.
doi: 10.1056/NEJMoa0808939 PMID: 20054045
19. Coutanceau E, Decalf J, Martino A, Babon A, Winter N, et al. (2007) Selective suppression of dendritic
cell functions by Mycobacterium ulcerans toxin mycolactone. J Exp Med 204: 1395–1403. Available:
http://jem.rupress.org/cgi/content/long/204/6/1395. Accessed 5 May 2014. doi: 10.1084/jem.20070234
PMID: 17517970
20. Durnez L, Stragier P, Roebben K, Ablordey A, Leirs H, et al. (2009) A comparison of DNA extraction
procedures for the detection of Mycobacterium ulcerans, the causative agent of Buruli ulcer, in clinical
and environmental specimens. J Microbiol Methods 76: 152–158. doi: 10.1016/j.mimet.2008.10.002
PMID: 18973778
21. Stinear T, Ross BC, Davies JK, Marino L, Robins-Browne RM, et al. (1999) Identification and character-
ization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans
by PCR. J Clin Microbiol 37: 1018–1023. PMID: 10074520
22. Glasner C, Sabat AJ, Dreisbach A, Larsen AR, Friedrich AW, et al. (2013) Rapid and high-resolution
distinction of community-acquired and nosocomial Staphylococcus aureus isolates with identical
pulsed-field gel electrophoresis patterns and spa types. Int J Med Microbiol 303: 70–75. doi: 10.1016/j.
ijmm.2012.12.005 PMID: 23369304
23. Jarraud S, Lyon GJ, Figueiredo AM, Gérard L, Vandenesch F, et al. (2000) Exfoliatin-producing strains
define a fourth agr specificity group in Staphylococcus aureus. J Bacteriol 182: 6517–6522. doi: 10.
1128/JB.182.22.6517-6522.2000 PMID: 11053400
24. Ji G, Beavis R, Novick RP (1997) Bacterial interference caused by autoinducing peptide variants. Sci-
ence 276: 2027–2030. doi: 10.1126/science.276.5321.2027 PMID: 9197262
25. Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, et al. (1995) Epidemiological data on Staphylococ-
cus aureus strains producing synergohymenotropic toxins. J Med Microbiol 42: 237–245. doi: 10.1099/
00222615-42-4-237 PMID: 7707330
26. Murakami K, MinamideW, Wada K, Nakamura E, Teraoka H, et al. (1991) Identification of methicillin-
resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 29: 2240–2244. Avail-
able: http://jcm.asm.org/content/29/10/2240.short. Accessed 6 May 2014. PMID: 1939577
Spatio-Temporal Distribution of S. aureus in BU
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003421 February 6, 2015 15 / 17
27. Sabat AJ, Chlebowicz MA, Grundmann H, Arends JP, Kampinga G, et al. (2012) Microfluidic-Chip-Based
Multiple-Locus Variable-Number Tandem-Repeat Fingerprinting with New Primer Sets for Methicillin-
Resistant Staphylococcus aureus. J Clin Microbiol 50: 2255–2262. doi: 10.1128/JCM.00056-12 PMID:
22573591
28. Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, et al. (2003) Typing of methicillin-resistant
Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determi-
nation and database management. J Clin Microbiol 41: 5442–5448. doi: 10.1128/JCM.41.12.5442-
5448.2003 PMID: 14662923
29. Tulloch LG (1954) Nasal carriage in staphylococcal skin infections. Br Med J 16: 912–913. doi: 10.
1136/bmj.2.4893.912
30. Toshkova K, Annemuller C, Akineden O, Lammler C (2001) The significance of nasal carriage of Staph-
ylococcus aureus as risk factor for human skin infections. FEMSMicrobiol Lett 202: 17–24. Available:
http://www.ncbi.nlm.nih.gov/pubmed/11506902. doi: 10.1016/S0378-1097(01)00287-7 PMID:
11506902
31. Van der Kooi-Pol MM, Veenstra-Kyuchukova YK, Duipmans JC, Pluister GN, Schouls LM, de Neeling
AJ, Grundmann H, JonkmanMF van DJ (2012) High genetic diversity of Staphylococcus aureus strains
colonizing patients with epidermolysis bullosa. Exp Dermatol 21: 463–466. doi: 10.1111/j.1600-0625.
2012.01502.x PMID: 22621190
32. Van der Kooi-Pol MM, Duipmans JC, JonkmanMF, Van Dijl JM (2014) Host-pathogen interactions in epi-
dermolysis bullosa patients colonized with Staphylococcus aureus. Int J Med Microbiol 304: 195–203.
doi: 10.1016/j.ijmm.2013.11.012 PMID: 24444717
33. Egyir B, Guardabassi L, SørumM, Nielsen SS, Kolekang A, et al. (2014) Molecular Epidemiology and
Antimicrobial Susceptibility of Clinical Staphylococcus aureus from Healthcare Institutions in Ghana.
PLoS One 9: e89716. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3934920&tool = pmcentrez&rendertype = abstract.doi: 10.1371/journal.pone.0089716 PMID: 24586981
34. Kahl BC, Mellmann A, Deiwick S, Peters G, Harmsen D (2005) Variation of the polymorphic region X of
the protein A gene during persistent airway infection of cystic fibrosis patients reflects two independent
mechanisms of genetic change in Staphylococcus aureus. J Clin Microbiol 43: 502–505. Available:
http://jcm.asm.org/content/43/1/502.full. Accessed 12 May 2014. doi: 10.1128/JCM.43.1.502-505.2005
PMID: 15635028
35. Van der Kooi-Pol MM, Sadaghian SadabadM, Duipmans JC, Sabat AJ, Stobernack T, et al. (2013) To-
pography of Distinct Staphylococcus aureus Types in Chronic Wounds of Patients with Epidermolysis
Bullosa. PLoS One 8. doi: 10.1371/journal.pone.0067272 PMID: 23825650
36. Price JR, Golubchik T, Cole K, Wilson DJ, Crook DW, et al. (2014) Whole-genome sequencing shows
that patient-to-patient transmission rarely accounts for acquisition of staphylococcus aureus in an inten-
sive care unit. Clin Infect Dis 58: 609–618. doi: 10.1093/cid/cit807 PMID: 24336829
37. Köser CU, Holden MTG, Ellington MJ, Cartwright EJP, Brown NM, et al. (2012) Rapid Whole-Genome
Sequencing for Investigation of a Neonatal MRSA Outbreak. N Engl J Med 366: 2267–2275. doi: 10.
1056/NEJMoa1109910 PMID: 22693998
38. Harris SR, Cartwright EJP, Torok ME, Holden MTG, Brown NM, et al. (2013) Whole-genome sequenc-
ing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: A descriptive study. Lan-
cet Infect Dis 13: 130–136. doi: 10.1016/S1473-3099(12)70268-2 PMID: 23158674
39. Kolawole DO, Adeyanju A, Schaumburg F, Akinyoola AL, Lawal OO, et al. (2013) Characterization of
Colonizing Staphylococcus aureus Isolated from Surgical Wards’ Patients in a Nigerian University Hos-
pital. PLoS One 8. doi: 10.1371/journal.pone.0068721 PMID: 23935883
40. Ramdani-Bouguessa N, BesM, Meugnier H, Forey F, ReverdyM-E, et al. (2006) Detection of methicillin-
resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine
leukocidin genes in an Algiers hospital. Antimicrob Agents Chemother 50: 1083–1085. doi: 10.1128/AAC.
50.3.1083-1085.2006 PMID: 16495274
41. Conceição T, Silva IS, de Lencastre H, Aires-de-Sousa M (2014) Staphylococcus aureus Nasal Car-
riage Among Patients and Health Care Workers in São Tomé and Príncipe. Microb Drug Resist
20: 57–66. Available: http://www.ncbi.nlm.nih.gov/pubmed/24024594. doi: 10.1089/mdr.2013.0136
PMID: 24024594
42. Djoudi F, Bonura C, Benallaoua S, Touati A, Touati D, et al. (2013) Panton-Valentine leukocidin positive
sequence type 80 methicillin-resistant Staphylococcus aureus carrying a staphylococcal cassette
chromosome mec type IVc is dominant in neonates and children in an Algiers hospital. NewMicrobiol
36: 49–55. Available: http://www.ncbi.nlm.nih.gov/pubmed/23435815. PMID: 23435815
43. Lina G, Boutite F, Tristan A, Bes M, Etienne J, et al. (2003) Bacterial competition for human nasal cavity
colonization: role of Staphylococcal agr alleles. Appl Environ Microbiol 69: 18–23. doi: 10.1128/AEM.
69.1.18-23.2003 PMID: 12513972
Spatio-Temporal Distribution of S. aureus in BU
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003421 February 6, 2015 16 / 17
44. Tsompanidou E, Sibbald MJJB, Chlebowicz MA, Dreisbach A, Back JW, et al. (2011) Requirement of
the agr locus for colony spreading of Staphylococcus aureus. J Bacteriol 193: 1267–1272. doi: 10.
1128/JB.01276-10 PMID: 21169484
45. Fischer J, Lee JC, Peters G, Kahl BC (2013) Acapsular clinical Staphylococcus aureus isolates lack
agr function. Clin Microbiol Infect: 1–4. Available: http://www.ncbi.nlm.nih.gov/pubmed/24224619. doi:
10.1111/1469-0691.12429 PMID: 24224619
46. Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC (2013) The role of the Panton-Valentine leucoci-
din toxin in staphylococcal disease: A systematic review andmeta-analysis. Lancet Infect Dis 13: 43–54.
doi: 10.1016/S1473-3099(12)70238-4 PMID: 23103172
47. Loffler B, Hussain M, Grundmeier M, Bruck M, Holzinger D, et al. (2010) Staphylococcus aureus
panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6. doi:
10.1371/journal.ppat.1000715 PMID: 20072612
Spatio-Temporal Distribution of S. aureus in BU
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003421 February 6, 2015 17 / 17
